Serial circulating tumor DNA to predict early recurrence in patients with hepatocellular carcinoma: a prospective study

Serial circulating tumor DNA to predict early recurrence in patients with hepatocellular carcinoma: a prospective study

We studied the value of circulating tumor DNA (ctDNA) in predicting early postoperative tumor recurrence and monitoring tumor burden in patients with hepatocellular carcinoma (HCC). Plasma‐free DNA, germline DNA, and tissue DNA were isolated from 41 patients with HCC. Serial ctDNAs were analyzed by...

Full description

Bibliographic Details
Main Authors: Gui‐Qi Zhu, Wei‐Ren Liu, Zheng Tang, Wei‐Feng Qu, Yuan Fang, Xi‐Fei Jiang, Shu‐Shu Song, Han Wang, Chen‐Yang Tao, Pei‐Yun Zhou, Run Huang, Jun Gao, Hai‐Xiang Sun, Zhen‐Bin Ding, Yuan‐Fei Peng, Zhi Dai, Jian Zhou, Jia Fan, Ying‐Hong Shi
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Molecular Oncology
Subjects:
biomarker
ctDNA
hepatocellular carcinoma
tumor recurrence
Online Access:https://doi.org/10.1002/1878-0261.13105

Internet

https://doi.org/10.1002/1878-0261.13105

Similar Items